During the past decade, San Francisco Oncology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Francisco Oncology Associates" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "BioVex Limited" with 1 trials sponsored, "California Pacific Medical Center Research Institute" with 1 trials sponsored, "IDEAYA Biosciences" with 1 trials sponsored and "Immune Design" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Francisco Oncology Associates" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "San Francisco Oncology Associates" are "Melanoma" (3 trials), "Metastatic Melanoma" (2 trials), "Renal Cell Carcinoma" (2 trials), "Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "San Francisco Oncology Associates" in a lesser frequency.

Most popular intervention types in "San Francisco Oncology Associates" are "Drug" (9 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (3 trials), "Nivolumab" (3 trials), "Bempegaldesleukin" (1 trials), "Bevacizumab" (1 trials) and "Binimetinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Francisco Oncology Associates" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "San Francisco Oncology Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in San Francisco Oncology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Francisco Oncology Associates, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".